Solasia Pharma KK 4597.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 05/02/24 JST
27.00UNCH (UNCH)
Volume
1,820,100
52 week range
23.00 - 71.00
Loading...
  • Open26.00
  • Day High28.00
  • Day Low26.00
  • Prev Close27.00
  • 52 Week High71.00
  • 52 Week High Date12/13/23
  • 52 Week Low23.00
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap28.81M
  • Shares Out173.94M
  • 10 Day Average Volume2.91M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-40

KEY STATS

  • Open26.00
  • Day High28.00
  • Day Low26.00
  • Prev Close27.00
  • 52 Week High71.00
  • 52 Week High Date12/13/23
  • 52 Week Low23.00
  • 52 Week Low Date04/18/24
  • Market Cap28.81M
  • Shares Out173.94M
  • 10 Day Average Volume2.91M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-40

RATIOS/PROFITABILITY

  • EPS (TTM)-5.30
  • P/E (TTM)-5.09
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Solasia Pharma KK

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System...
Yoshihiro Arai
President, Director
Toshio Miyashita
Chief Financial Officer, Chief Director of Administration, Director
Address
3F, Shiodome Bldg., 1-2-20, Kaigan
Minato-ku, TKY
105-0011
Japan